EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Design and preliminary study of VP1-encoding mRNA-lipid nanoparticles for Enterovirus 71

Parnuphan Panyajai, Rujiraporn Pitaksalee, Apichai Prachasuphap, Kodcharad Jongpitisub, Pantida Treeyoung, Sirawit Wet-osot, Nalinee Saengtong, Nadthanan Pinyosukhee, Rattanawadee Wichajarn, Kritsamon Sophondilok, Anicha Luengchaichaweng, Panadda Dhepakson

Journal of Associated Medical Sciences · 29.06.2026 · 59 (3) · 196-204

DOI: 10.66285/jams.2026.093 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Associated Medical Sciences, online erschienen am 29.06.2026. Verfasst von Parnuphan Panyajai und 11 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Hand, foot, and mouth disease (HFMD) remains a major public health concern in the Asia-Pacific region, with Enterovirus 71 (EV71) being a major cause of severe neurological complications in children. The genetic diversity of EV71 highlights the need for adaptable vaccine platforms.

Objective

This study aimed to design and preliminarily evaluate an EV71 VP1-encoding mRNA-lipid nanoparticle (mRNA-LNP) construct as an antigen delivery approach for EV71 vaccine development. Materials and methods: A codon-optimized VP1 mRNA was synthesized by in vitro transcription and formulated into lipid nanoparticles via microfluidic mixing. Physicochemical properties were characterized, and in vitro expression was assessed in FreeStyle 293F cells by western blot and immunofluorescence. VP1-specific humoral immune responses were evaluated in BALB/c mice following a prime-boost immunization regimen using ELISA.

Results

The mRNA-LNPs exhibited a mean particle size of 99.24±0.46 nm, a low polydispersity index (0.041±0.004), a slightly negative zeta potential (-20.54±0.98 mV), and an encapsulation efficiency of 92.56±1.53%. In vitro studies demonstrated VP1 protein expression following mRNA delivery. Immunization induced VP1-specific IgG responses, with antibody levels significantly increased after prime (1.254±0.775) and boost (4.225±0.322) compared with control groups (p

Zitieren

APA

Panyajai, P., Pitaksalee, R., Prachasuphap, A., Jongpitisub, K., Treeyoung, P., Wet-osot, S., Saengtong, N., Pinyosukhee, N., Wichajarn, R., Sophondilok, K., Luengchaichaweng, A., & Dhepakson, P. (2026). Design and preliminary study of VP1-encoding mRNA-lipid nanoparticles for Enterovirus 71. Journal of Associated Medical Sciences, 59(3), 196-204. https://doi.org/10.66285/jams.2026.093

Vancouver

Panyajai P, Pitaksalee R, Prachasuphap A, Jongpitisub K, Treeyoung P, Wet-osot S, et al. Design and preliminary study of VP1-encoding mRNA-lipid nanoparticles for Enterovirus 71. Journal of Associated Medical Sciences. 2026;59(3):196-204. doi:10.66285/jams.2026.093

BibTeX
@article{Panyajai2026,
  author = {Panyajai, Parnuphan and Pitaksalee, Rujiraporn and Prachasuphap, Apichai and Jongpitisub, Kodcharad and Treeyoung, Pantida and Wet-osot, Sirawit and Saengtong, Nalinee and Pinyosukhee, Nadthanan and Wichajarn, Rattanawadee and Sophondilok, Kritsamon and Luengchaichaweng, Anicha and Dhepakson, Panadda},
  title = {Design and preliminary study of VP1-encoding mRNA-lipid nanoparticles for Enterovirus 71},
  journal = {Journal of Associated Medical Sciences},
  year = {2026},
  volume = {59},
  number = {3},
  pages = {196--204},
  doi = {10.66285/jams.2026.093}
}
Kostenlos starten →